Catalyst Pharmaceuticals Inc (CPRX)
15.29
-0.02 (-0.13%)
USD |
NASDAQ |
Feb 02, 10:23
Catalyst Pharmaceuticals Price to Book Value: 5.893 for Feb. 2, 2023
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
February 01, 2023 | 5.900 |
January 31, 2023 | 5.970 |
January 30, 2023 | 6.058 |
January 27, 2023 | 5.981 |
January 26, 2023 | 6.162 |
January 25, 2023 | 6.448 |
January 24, 2023 | 6.212 |
January 23, 2023 | 5.688 |
January 20, 2023 | 8.016 |
January 19, 2023 | 7.812 |
January 18, 2023 | 7.874 |
January 17, 2023 | 7.762 |
January 13, 2023 | 8.112 |
January 12, 2023 | 8.082 |
January 11, 2023 | 7.635 |
January 10, 2023 | 7.604 |
January 09, 2023 | 7.330 |
January 06, 2023 | 7.554 |
January 05, 2023 | 7.257 |
January 04, 2023 | 7.149 |
January 03, 2023 | 6.960 |
December 30, 2022 | 7.168 |
December 29, 2022 | 7.068 |
December 28, 2022 | 6.987 |
December 27, 2022 | 7.164 |
Date | Value |
---|---|
December 23, 2022 | 7.326 |
December 22, 2022 | 7.457 |
December 21, 2022 | 7.515 |
December 20, 2022 | 7.168 |
December 19, 2022 | 6.324 |
December 16, 2022 | 6.166 |
December 15, 2022 | 6.49 |
December 14, 2022 | 6.825 |
December 13, 2022 | 6.86 |
December 12, 2022 | 6.710 |
December 09, 2022 | 6.313 |
December 08, 2022 | 6.475 |
December 07, 2022 | 6.482 |
December 06, 2022 | 6.344 |
December 05, 2022 | 6.544 |
December 02, 2022 | 6.656 |
December 01, 2022 | 6.409 |
November 30, 2022 | 6.463 |
November 29, 2022 | 6.270 |
November 28, 2022 | 6.355 |
November 25, 2022 | 6.540 |
November 23, 2022 | 6.563 |
November 22, 2022 | 6.748 |
November 21, 2022 | 5.997 |
November 18, 2022 | 6.008 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.965
Minimum
Sep 30 2020
12.28
Maximum
May 06 2019
4.637
Average
4.316
Median
Apr 08 2020
Price to Book Value Benchmarks
ADMA Biologics Inc | 7.292 |
Rhythm Pharmaceuticals Inc | 5.597 |
Merrimack Pharmaceuticals Inc | 11.95 |
Xencor Inc | 2.846 |
Jaguar Health Inc | 2.488 |
Price to Book Value Related Metrics
PE Ratio | 25.07 |
PS Ratio | 8.752 |
PEG Ratio | 0.4443 |
Price to Free Cash Flow | 17.65 |
Price | 15.29 |
Earnings Yield | 3.99% |
Market Cap | 1.591B |
PEGY Ratio | 0.4443 |
Operating PE Ratio | 20.03 |
Normalized PE Ratio | 25.07 |